HEALTHY ROUTINES TO MAKE THE MOST OF YOUR TREATMENT

Sticking to a routine and establishing realistic goals can go a long way in helping you manage the symptoms of IBS-C (Irritable Bowel Syndrome with Constipation) and CIC (Chronic Idiopathic Constipation).

A woman stirs a glass of water with OTC IBS-C or CIC medication.

OTC & Prescription Treatments

Get a closer look at how some of the most common OTCs work and learn more about prescription treatment LINZESS.

Read the article

A bowl of salad and other healthy leafy greens.

Tackling IBS-C Triggers

Once you know what causes flare-ups, you can avoid those triggers, find exciting substitutions, and make the most of your treatment.

Read the article

An IBS-C or CIC patient discusses her symptoms with her doctor.

Keeping in Touch with Your Doctor

It’s important to have clear and honest conversations with your doctor. Get tips to make the most of your next appointment.

Read the article

GET FOOD & DIET TIPS

COMMUNITY RESOURCES

A recipe book, savings card, phone with SMS medication reminders, and a tablet open to LINZESS.com.

SIGN UP FOR TIPS & RESOURCES FOR LIVING WITH IBS-C AND CIC

Get tips, resources, and more information about IBS-C and CIC, plus savings for commercially eligible patients on LINZESS right to your inbox.

NEW TO LINZESS?

We can help you manage your IBS-C or CIC symptoms.

LINZESS is a once-daily pill that’s proven to treat multiple symptoms of IBS-C. It helps you have more frequent and complete bowel movements and helps relieve constipation and overall abdominal symptoms* (belly pain, discomfort, and bloating) associated with IBS-C.

LEARN HOW LINZESS CAN HELP

*Abdominal symptoms were studied in combination, not individually.

*Third-party website; does not constitute an endorsement or recommendation by AbbVie. A fee will be charged by the telemedicine provider.

You are now leaving LINZESS.com

By clicking “Acknowledge and Continue” above, you acknowledge and agree that neither AbbVie nor Ironwood does, in any way, endorse or recommend UpScript, a telemedicine provider, the qualifications of any physician associated with UpScript, or the quality of medical care any of those physicians can provide. You also acknowledge and agree that neither AbbVie nor Ironwood makes any guarantees that using UpScript will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie and Ironwood recommend that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE, IRONWOOD, AND THEIR RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE UPSCRIPT WEBSITE. If you agree to the above, click “Acknowledge and Continue” to proceed to the UpScript website. If you do not agree to the above, click “Cancel” to remain on LINZESS.com.

IMPORTANT RISK INFORMATION

Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).

Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

IMPORTANT RISK INFORMATION

Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take LINZESS, tell your doctor about your medical conditions, including if you are:

HEALTHY ROUTINES TO MAKE THE MOST OF YOUR TREATMENT

HEALTHY ROUTINES TO MAKE THE MOST OF YOUR TREATMENT

Sticking to a routine and establishing realistic goals can go a long way in helping you manage the symptoms of IBS-C (Irritable Bowel Syndrome with Constipation) and CIC (Chronic Idiopathic Constipation).

OTC & Prescription Treatments

Tackling IBS-C Triggers

Keeping in Touch with Your Doctor

SIGN UP FOR TIPS & RESOURCES FOR LIVING WITH IBS-C AND CIC

NEW TO LINZESS?

USES

IMPORTANT RISK INFORMATION

USES

IMPORTANT RISK INFORMATION

IMPORTANT RISK INFORMATION

USES

IMPORTANT RISK INFORMATION

IMPORTANT RISK INFORMATION

USES

IMPORTANT RISK INFORMATION